Moreover, CUR and its derivates express anticancer activity, suppressing the proliferation of these tumor cell lines, modifying the deregulated cell cycle through p53-dependent, p53-independent, and cyclin-dependent pathways. The gene discussed is TP53; the disease is neoplasm.